<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=Diabetes%26drug&amp;format=rss"><channel><title>Diabetes&amp;drug - BingNews</title><link>http://www.bing.com/news/search?q=Diabetes%26drug&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>Diabetes&amp;drug</title><link>http://www.bing.com/news/search?q=Diabetes%26drug&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Diabetes drug metformin could reduce insulin needs for people with type 1 diabetes: Study</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.msn.com%2fen-in%2fhealth%2fdiseases-and-conditions%2fdiabetes-drug-metformin-could-reduce-insulin-needs-for-people-with-type-1-diabetes-study%2far-AA218CTc&amp;c=1045092588999497467&amp;mkt=en-us</link><description>Researchers tested the drug on 40 adults with long-term type 1 diabetes in the Insulin Resistance in Type 1 Diabetes Managed with Metformin (INTIMET) study, giving half of them metformin and half a ...</description><pubDate>Fri, 17 Apr 2026 11:11:50 GMT</pubDate><News:Source>NDTV on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.FtK-w546_IFzU7uKTLLMLQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>738</News:ImageMaxHeight></item><item><title>For 2 Million Americans, the Future of Type 1 Diabetes Care is Now</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.ucsf.edu%2fnews%2f2026%2f04%2f431741%2f2-million-americans-future-type-1-diabetes-care-now&amp;c=18121189642416941023&amp;mkt=en-us</link><description>UCSF research led to the first type 1 diabetes immunotherapy. Now, scientists are using stem cells and Tregs to find a functional cure.</description><pubDate>Thu, 16 Apr 2026 10:05:00 GMT</pubDate><News:Source>University of California, San Francisco</News:Source><News:Image>http://www.bing.com/th?id=ONUT.wjPgI2YoSM9PCUZXQ6YJJA&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1360</News:ImageMaxWidth><News:ImageMaxHeight>900</News:ImageMaxHeight></item><item><title>Maryland caps diabetes drug costs for government health plans</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fmaryland-caps-diabetes-drug-costs-for-government-health-plans%2far-AA20N85h&amp;c=8407874892121446292&amp;mkt=en-us</link><description>Maryland regulators voted Monday to cap what government health plans pay for the Type 2 diabetes drug Jardiance, a move officials say will sharply cut costs for taxpayers and could expand statewide.</description><pubDate>Mon, 13 Apr 2026 12:56:00 GMT</pubDate><News:Source>The Baltimore Sun on MSN</News:Source><News:Image>http://www.bing.com/th?id=ORMS.36783c7ae01094b95626031436f51cd3&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>774</News:ImageMaxWidth><News:ImageMaxHeight>516</News:ImageMaxHeight></item><item><title>Incretin-Based Drugs Show Superior Glycemic Profiles on CGM</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.medscape.com%2fviewarticle%2fincretin-based-drugs-show-superior-glycemic-profiles-cgm-2026a1000bxo&amp;c=7130886123009669486&amp;mkt=en-us</link><description>Continuous glucose monitoring in the GRADE trial shows that incretin-based drugs such as sitagliptin and liraglutide produce the most stable glycemic profiles and show the lowest hypoglycemia risk.</description><pubDate>Thu, 16 Apr 2026 06:36:00 GMT</pubDate><News:Source>Medscape</News:Source></item><item><title>Maryland board votes to cap the cost of a common diabetes drug for state and local government agencies</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.wmar2news.com%2fnews%2fstate%2fmaryland-board-votes-to-cap-the-cost-of-a-common-diabetes-drug-for-state-and-local-government-agencies&amp;c=14640266360103324231&amp;mkt=en-us</link><description>Maryland's Prescription Drug Affordability Board voted to cap how much government agencies pay for Jardiance, saving about $320,000 a year.</description><pubDate>Wed, 15 Apr 2026 19:20:00 GMT</pubDate><News:Source>WMAR 2 News</News:Source><News:Image>http://www.bing.com/th?id=ONUT.hNmoTvSc7JwWcVFHotGXfQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>630</News:ImageMaxHeight></item><item><title>Lilly's Foundayo pill clears heart safety bar in diabetes trial</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2farticles%2flillys-foundayo-pill-clears-heart-144425065.html&amp;c=6717999612712778596&amp;mkt=en-us</link><description>Lilly plans to file Foundayo with the FDA for type 2 diabetes by end of Q2 after the ACHIEVE-4 trial met its primary cardiovascular endpoint ...</description><pubDate>Thu, 16 Apr 2026 07:57:00 GMT</pubDate><News:Source>Yahoo</News:Source><News:Image>http://www.bing.com/th?id=ONUT.MTwNa3qbY78FWbIZjVnFYA&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>675</News:ImageMaxHeight></item><item><title>Advocates ‘thrilled’ by state decision to cap spending on diabetes drug Jardiance</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2farticles%2fadvocates-thrilled-state-decision-cap-014101449.html&amp;c=17930823856503688333&amp;mkt=en-us</link><description>Health care advocates on Wednesday hailed recent steps to limit how much state health plans will pay for a popular a Type 2 diabetes drug, a move that could save state and local governments an ...</description><pubDate>Wed, 15 Apr 2026 20:02:00 GMT</pubDate><News:Source>Yahoo</News:Source><News:Image>http://www.bing.com/th?id=ONUT.xyEn71wNbkZBB3KFCG0cLg&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>896</News:ImageMaxWidth><News:ImageMaxHeight>504</News:ImageMaxHeight></item><item><title>Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2flilly-answers-fdas-call-more-foundayo-safety-info-plotting-diabetes-filing-parallel&amp;c=11074741911888118263&amp;mkt=en-us</link><description>The results seen with Foundayo, also known as orforglipron, enabled Lilly’s late-stage Achieve-4 study to hit its primary endpoint. Specifically, the drug demonstrated non-inferiority to insulin ...</description><pubDate>Thu, 16 Apr 2026 06:43:00 GMT</pubDate><News:Source>Fierce Pharma</News:Source><News:Image>http://www.bing.com/th?id=ONUT.UmBly5FAWtQtPmyQ6MEbLQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1024</News:ImageMaxWidth><News:ImageMaxHeight>638</News:ImageMaxHeight></item><item><title>New Advances in Diabetes Drugs Are Transforming Treatment of Liver Disease</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.ajmc.com%2fview%2fnew-advances-in-diabetes-drugs-are-transforming-treatment-of-liver-disease&amp;c=2884846122536582957&amp;mkt=en-us</link><description>Emerging diabetes therapies are transforming MASLD treatment by addressing both metabolic dysfunction and liver disease, with new approvals and a growing pipeline signaling a shift in care. A rapidly ...</description><pubDate>Sun, 29 Mar 2026 04:34:00 GMT</pubDate><News:Source>The American Journal of Managed Care</News:Source></item><item><title>Diabetes drug metformin may echo the benefits of exercise in prostate cancer care</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fdiabetes-drug-metformin-may-echo-the-benefits-of-exercise-in-prostate-cancer-care%2far-AA20eXfb&amp;c=6123441798312940531&amp;mkt=en-us</link><description>A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects in men with prostate cancer, raising levels of a molecule tied to energy ...</description><pubDate>Mon, 06 Apr 2026 02:25:00 GMT</pubDate><News:Source>Medical Xpress on MSN</News:Source><News:Image>http://www.bing.com/th?id=ORMS.6b77436b36270ad4f93688bfd35da93e&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>2880</News:ImageMaxWidth><News:ImageMaxHeight>1920</News:ImageMaxHeight></item><item><title>Genetic link found: Why GLP-1 diabetes drugs may fail</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.msn.com%2fen-in%2fhealth%2fdiseases-and-conditions%2fgenetic-link-found-why-glp-1-diabetes-drugs-may-fail%2far-AA218QXt&amp;c=18443205780263308128&amp;mkt=en-us</link><description>India, April 17 -- Approximately 10% of the population carries specific genetic variants that cause GLP-1 (Glucagon-like peptide-1) resistance, significantly reducing the effectiveness of popular Type ...</description><pubDate>Fri, 17 Apr 2026 09:23:00 GMT</pubDate><News:Source>Medindia on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.pbr4eWDfsMMJ6aW1m8af1Q&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>1000</News:ImageMaxHeight></item><item><title>Weight loss, diabetes drug Ozempic does not work for some people, scientists have figured out why</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e27f68600c42c5889c0905965766d0&amp;url=https%3a%2f%2fwww.moneycontrol.com%2fhealth-and-fitness%2fweight-loss-diabetes-drug-ozempic-does-not-work-for-some-people-scientists-have-figured-out-why-article-13887322.html&amp;c=10107631206774247793&amp;mkt=en-us</link><description>Scientists say a hidden genetic difference may explain why weight-loss and diabetes drugs like Ozempic and Wegovy don’t work for everyone. They say around 10% of people may carry gene variants that ...</description><pubDate>Sun, 12 Apr 2026 23:48:00 GMT</pubDate><News:Source>Moneycontrol</News:Source><News:Image>http://www.bing.com/th?id=ONUT._mykqRBdkhpRFps8BoSsdQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1280</News:ImageMaxWidth><News:ImageMaxHeight>720</News:ImageMaxHeight></item></channel></rss>